Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: March 1, 2006
Last updated: June 11, 2008
Last verified: June 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given